Search Results 851-860 of 11394 for anti-TNF drugs
... anti-PD1/PDL-1 therapy. Exclusion Criteria: Concurrent active malignancy. Major surgery within 4 weeks of treatment. Subjects with active, known or ...
Early trial results suggest a new drug combination may help overcome treatment resistance in kidney cancer. Learn more.
patient has received anti-PD-[L]1 therapy ± anti-CTLA-4 therapy, and ≤ 1 other prior regimen of systemic anti-neoplastic therapy;; patient should have ...
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetic, pharmacodynamic, preliminary anti-tumor activity, and to determine the ...
Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...
A Mayo Clinic nanotherapy crossed the blood-brain barrier in laboratory models, sending cancer drugs directly to GBM tumors. The therapy boosted the tumors' ...
Ausman, "either the wrong dosage or the wrong medication for the condition." Historically, the Antimicrobial Stewardship team has seen patients prescribed ...
Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices. ... treatment with systemic anti-lymphoma therapy. 5 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.